Revolutionary treatment for menopausal symptoms: Veozah (Fezolinetant) receives FDA approval.

Ann Med Surg (Lond)

Department of Research Education, Bagira, Bukavu, South Kivu, DR Congo.

Published: December 2024

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11623885PMC
http://dx.doi.org/10.1097/MS9.0000000000001659DOI Listing

Publication Analysis

Top Keywords

revolutionary treatment
4
treatment menopausal
4
menopausal symptoms
4
symptoms veozah
4
veozah fezolinetant
4
fezolinetant receives
4
receives fda
4
fda approval
4
revolutionary
1
menopausal
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!